Zagro: striving for rapid growth in Asia and beyond
For a small-sized animal health business, Zagro is certainly making its presence felt in the industry. The company may be based in Singapore, but its outlook and business activities are definitely global. It has been a publicly listed company for the past 10 years and made the headlines last year with its purchase of the BASF premix manufacturing plant in Taiwan. Animal Pharm speaks to Zagro's chief executive, Poh Beng Poh, to find out more about the company's plans for the future and the challenges that lie ahead.